Recombinant Human Anti-IAV HA Antibody (FI6V3)
Recombinant Human Antibody (FI6V3) is capable of binding to IAV HA, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-IAV HA mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-IAV HA mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions.
Recombinant Human Anti-IAV HA Antibody (FI6V3)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Recombinant Human Antibody (FI6V3) is capable of binding to IAV HA, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-IAV HA mAb and the CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-IAV HA mAb and CL of human kappa light chain. Exists as a disulfide-linked dimer of the HC and LC heterodimer under non-reducing conditions. It is designed to support reliable, reproducible results in modern laboratories. It helps streamline your workflow, reduce troubleshooting, and deliver consistent performance across batches. Prominent attributes include productname and abbr.
Manufactured under rigorous quality controls, each lot is checked for key specifications to ensure lot‑to‑lot consistency. The format is optimized for ease of use and integration into existing protocols, with documentation available upon request.
Key Features / Benefits
- productname: Recombinant Human Anti-IAV HA Antibody (FI6V3)
- abbr: Recombinant Human Anti-IAV HA Antibody (FI6V3)
- Target: HA
- Host Animal: Human
- Specificity: Tested positive against native IAV HA
- Immunogen: Influenza A virus Hemagglutinin
Relevant Applications
- ELISA
- Neut
- WB
- IHC
- FuncS
- The antibody was validated for ELISA
- Neutralization. For details refer to Published Data.
